Investor
ChemistryCheck size: Chemistry leads early-stage rounds with commitments up to $30M, according to its official company description.
Ayaan Momin invests or supports investments through Chemistry's published strategy: Lead concentrated early-stage investments in software founders who combine technical expertise with strong commercial instincts, with the whole firm supporting each company.
Technically credible founders with sharp commercial instincts, strong founder-team chemistry and potential to build breakout software companies.
No formal pass list is public. Opportunities without technical depth, commercial judgment or a fit for concentrated early-stage software investing appear less aligned.
Show the technical insight, commercial wedge, customer pull, why this team is uniquely suited to win and how a concentrated hands-on investor can materially help.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Ayaan Momin is a current Investor at Chemistry, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.